Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:        
Net loss $ (8,295) $ (15,207) $ (29,086) $ (31,209)
Adjustments to reconcile net loss to cash used in operating activities:        
Depreciation and amortization     1,584 1,641
Stock-based compensation expense 724 2,428 1,586 4,378
Non-cash impairment of licensed technology 1,355
Non-cash impairment of right-of-use lease asset 1,561
Non-cash impairment of construction-in-progress     1,792
Accretion and interest on short-term investments     (177) 266
Amortization of right-of-use lease assets     899 543
Non-cash interest     402
Loss on disposal of property and equipment     106
Change in operating assets and liabilities:        
Accounts receivable     2,000
Other receivables     (1,827)
Prepaid expenses and other current assets     937 1,387
Other assets     148 (22)
Accounts payable, accrued expenses and lease liabilities     (3,684) (4,977)
Change in payable to licensor     (296) 2,919
Net cash used in operating activities     (22,700) (25,074)
Cash flows from investing activities:        
Capital expenditures     (103) (501)
Proceeds from disposal of property and equipment     1,487
Purchases of short-term investments     (34,442) (15,164)
Proceeds from maturities of short-term investments     32,735 46,965
Net cash (used in) provided by investing activities     (323) 31,300
Cash flows from financing activities:        
Proceeds from open market sales of common stock     7,666
Proceeds from exercise of stock options     691
Proceeds from issuance of Series A and Series B Convertible Redeemable Preferred Stock, net of issuance costs     22,468
Redemption of Series A and Series B Convertible Redeemable Preferred Stock     (26,250)
Net cash (used in) provided by financing activities     (3,782) 8,357
Net increase (decrease) in cash, cash equivalents and restricted cash     (26,805) 14,583
Cash, cash equivalents and restricted cash at beginning of period     38,829 13,571
Cash, cash equivalents and restricted cash at end of period 12,024 28,154 12,024 28,154
Supplemental cash flow information:        
Cash and cash equivalents 6,133 27,179 6,133 27,179
Restricted cash 5,891 975 5,891 975
Total cash, cash equivalents and restricted cash $ 12,024 $ 28,154 $ 12,024 $ 28,154